Laura Sepp-Lorenzino

Laura Sepp-Lorenzino

Director/Board Member at TAYSHA GENE THERAPIES, INC.

Net worth: 872 474 $ as of 30/01/2025

64 year
Health Technology
Consumer Services
Commercial Services

Profile

Dr. Laura Sepp-Lorenzino is an Independent Director at Taysha Gene Therapies, Inc. and a Chief Scientific Officer & Executive VP at Intellia Therapeutics, Inc. She is on the Board of Directors at Taysha Gene Therapies, Inc. Dr. Sepp-Lorenzino was previously employed as a VP, Head-Nucleic Acid Therapies & Research by Vertex Pharmaceuticals, Inc., a Vice President by Alnylam Pharmaceuticals, Inc., and an Executive Director & Head-RNA Therapeutics by Merck & Co., Inc. She received her undergraduate degree from Universidad de Buenos Aires, a graduate degree from New York University and a doctorate degree from New York University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
02/01/2025 77,388 ( 0.08% ) 798 644 $ 30/01/2025
28/05/2024 49,220 ( 0.02% ) 73 830 $ 30/01/2025

Laura Sepp-Lorenzino active positions

CompaniesPositionStart
TAYSHA GENE THERAPIES, INC. Director/Board Member 22/11/2020
Director/Board Member -
Director/Board Member -
All active positions of Laura Sepp-Lorenzino

Former positions of Laura Sepp-Lorenzino

CompaniesPositionEnd
INTELLIA THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 12/01/2025
VERTEX PHARMACEUTICALS INCORPORATED Corporate Officer/Principal 30/04/2019
ALNYLAM PHARMACEUTICALS, INC. Corporate Officer/Principal 31/08/2017
MERCK & CO., INC. Director/Board Member 28/02/2014
See the detail of Laura Sepp-Lorenzino's experience

Training of Laura Sepp-Lorenzino

New York University
Doctorate Degree
Universidad de Buenos Aires
Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Laura Sepp-Lorenzino's experience

Connections

98

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies5
INTELLIA THERAPEUTICS, INC.

Health Technology

VERTEX PHARMACEUTICALS INCORPORATED

Health Technology

ALNYLAM PHARMACEUTICALS, INC.

Health Technology

MERCK & CO., INC.

Health Technology

TAYSHA GENE THERAPIES, INC.

Health Technology

Private companies2

Commercial Services

Health Services

See company connections
  1. Stock Market
  2. Insiders
  3. Laura Sepp-Lorenzino